Stacker on MSN

10 European countries with great study options for US students in 2026

HousingAnywhere reports on 10 European countries ideal for US students, highlighting study options, cultures, and ...
STAT

Gene therapy spurs improvement in rare neuromuscular disease

Kids and teenagers with spinal muscular atrophy had more mobility after receiving a single-dose gene replacement therapy, ...

Investors Back Parallel’s $20 Million Series B To Transform Special Education

As special education shortages intensify, Parallel Learning’s $20M raise shows how virtual services and measurable outcomes ...
South Florida Reporter

5 Ways to Find Quality Pain Management Services

Pain often crosses medical and lifestyle lines, so teams work better than isolated visits. Look for offices that include, or ...
Main Line Today

Primary Care Physicians Around the Main Line Are a Dying Breed

Faced with increasing operational costs, primary care physicians are repurposing or turning to health networks.

Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data highlighting the potential of ...

Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)

Genmab A/S (Nasdaq: GMAB) today announced new and updated data from three arms of the ongoing Phase 1b/2 EPCORE® CLL-1 trial (NCT04623541) evaluating the efficacy and safety of epcoritamab-bysp, a ...